{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:23:51Z","timestamp":1790180631010,"version":"4.1.0"},"reference-count":64,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Cancer"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Digital interventions have been increasingly applied in multidisciplinary care plans to improve medication adherence to oral systemic anticancer therapy (SACT), the crucial lifesaving treatments for many cancers. However, there is still a lack of consensus on the efficacy of those digital interventions.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n This systematic review and meta-analysis aimed to investigate the efficacy of digital interventions in improving adherence to oral SACTs in patients with cancer.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n This systematic review and meta-analysis followed the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement guidelines. The protocol has been registered at PROSPERO (no. CRD42024550203). Fully published, randomized controlled trials (RCTs) in English on adults with cancer assessing digital interventions for improving adherence to oral SACTs were retrieved from MEDLINE, Embase, APA PsycINFO, and CINAHL Plus up to May 31, 2024. Adherence measures compared between digital intervention users and nonusers were extracted. The proportions of poor adherence were synthesized using a random-effects model. The pooled results were reported as the odds ratio and 95% CI. The heterogeneity was assessed with the\n I<\/jats:italic>\n 2<\/jats:sup>\n test (%). The mean difference and 95% CI were calculated from the mean adherence score and SD. A risk of bias assessment was conducted using version 2 of the Cochrane Risk of Bias Assessment Tool (RoB 2) for RCTs, which ensured that a quality assessment of all included studies was conducted as recommended by the Cochrane Collaboration.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n This study included 13 RCTs on digital interventions for improving adherence to oral SACTs in patients with cancer. The 13 RCTs, published between 2016 and 2024, were conducted in the United States, South Korea, France, Egypt, Finland, Australia, Colombia, Singapore, and Turkey. The technologies used were mobile apps (n=4), reminder systems (n=4), telephone follow-ups (n=3), and interactive multimedia platforms (n=2). Adherence was measured by surveys (n=8), relative dose intensity (n=2), pill count (n=1), self-reported missed doses (n=1), a smart pill bottle (n=1), and urine aromatase inhibitor metabolite assays (n=1). Concerns regarding risk of bias primarily involved randomization, missing outcome data, and outcome measurement, including nonblinded randomization, subjective patient-reported data, and difficulties in distinguishing between missed appointments and actual medication nonadherence. Pooled results from 11 trials showed that digital technology users had significantly lower risk of poor adherence (odds ratio 0.60, 95% CI 0.47\u20100.77). Two studies reported positive mean differences in adherence scores comparing digital intervention users and nonusers. However, due to considerable heterogeneity (\n I<\/jats:italic>\n \u00b2=73.1%), it is difficult to make a definitive conclusion from the pooled results about the effect of digital interventions upon adherence to oral anticancer therapy.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Digital intervention users exhibited significantly lower risk of poor oral SACTs adherence than nonusers. Acknowledging individual variation and tailoring digital technologies to prioritize patient needs is essential.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/64208","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T13:41:17Z","timestamp":1736948477000},"page":"e64208-e64208","source":"Crossref","is-referenced-by-count":11,"title":["The Efficacy of Digital Interventions on Adherence to Oral Systemic Anticancer Therapy Among Patients With Cancer: Systematic Review and Meta-Analysis"],"prefix":"10.2196","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0757-5432","authenticated-orcid":false,"given":"Wan-Chuen","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0547-1656","authenticated-orcid":false,"given":"Fiona","family":"Angus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5058-8123","authenticated-orcid":false,"given":"Jane","family":"Conley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6158-6645","authenticated-orcid":false,"given":"Li-Chia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"issue":"3","key":"R1","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.ahj.2011.06.007","article-title":"Medication adherence: a call for action","volume":"162","author":"Bosworth","journal-title":"Am Heart J"},{"issue":"1","key":"R2","first-page":"87","volume":"32","author":"Pituskin","journal-title":"Can Oncol Nurs J"},{"issue":"4","key":"R3","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1586\/14737140.2016.1159515","article-title":"Medication adherence to oral anticancer drugs: systematic review","volume":"16","author":"Huang","journal-title":"Expert Rev Anticancer Ther"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1177\/10781552241259354","article-title":"Investigating adherence to tyrosine kinase inhibitors in renal cancer","volume":"29","author":"Angus","journal-title":"J Oncol Pharm Pract"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2015.08.025","article-title":"To adhere or not to adhere: rates and reasons of medication adherence in hematological cancer patients","volume":"97","author":"Hall","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"R6","doi-asserted-by":"publisher","first-page":"290","DOI":"10.4103\/apjon.apjon_35_17","article-title":"The effect of structured education to patients receiving oral agents for cancer treatment on medication adherence and self-efficacy","volume":"4","author":"Tokdemir","journal-title":"Asia Pac J Oncol Nurs"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S126651","article-title":"Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review","volume":"11","author":"Moon","journal-title":"Patient Prefer Adherence"},{"issue":"2","key":"R8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10549-017-4317-2","article-title":"Breast cancer oral anti-cancer medication adherence: a systematic review of psychosocial motivators and barriers","volume":"165","author":"Lin","journal-title":"Breast Cancer Res Treat"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2021.102026","article-title":"A mixed methods analysis of the monitoring of oral anti-cancer therapies","volume":"54","author":"O\u2019Mahony","journal-title":"Eur J Oncol Nurs"},{"issue":"2","key":"R10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2143\/ACB.66.2.2062525","article-title":"Patient adherence to oral anticancer drugs: an emerging issue in modern oncology","volume":"66","author":"Foulon","journal-title":"Acta Clin Belg"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.2147\/CA.S30125","article-title":"Medication adherence issues in patients: focus on cost","volume":"2013","author":"Matsui","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"R12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/phar.1399","article-title":"Improving adherence to oral cancer therapy in clinical practice","volume":"34","author":"McCue","journal-title":"Pharmacotherapy"},{"issue":"4","key":"R13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/ejhpharm-2018-001725","article-title":"Medication adherence interventions and outcomes: an overview of systematic reviews","volume":"26","author":"Wilhelmsen","journal-title":"Eur J Hosp Pharm"},{"issue":"1","key":"R14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s13187-023-02374-w","article-title":"A novel digital educational strategy improves treatment adherence and quality of life in patients with multiple myeloma","volume":"39","author":"Guio","journal-title":"J Cancer Educ"},{"issue":"2","key":"R15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.2044-8260.1979.tb00333.x","article-title":"Memory for medical information","volume":"18","author":"Ley","journal-title":"Br J Soc Clin Psychol"},{"issue":"6","key":"R16","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1080\/14740338.2020.1764935","article-title":"Toward digital-based interventions for medication adherence and safety","volume":"19","author":"Haga","journal-title":"Expert Opin Drug Saf"},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Gogia S . Chapter 1\u2014overview. In: Gogia S , editor. Fundamentals of Telemedicine and Telehealth. Academic Press; 2020:3-10.","DOI":"10.1016\/B978-0-12-814309-4.00001-X"},{"issue":"6","key":"R18","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1109\/TSMCC.2012.2189204","article-title":"A review of smart homes\u2014past, present, and future","volume":"42","author":"Alam","journal-title":"IEEE Trans Syst, Man, Cybern C"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S26314","article-title":"The effect of reminder systems on patients\u2019 adherence to treatment","volume":"6","author":"Fenerty","journal-title":"Patient Prefer Adherence"},{"issue":"6","key":"R20","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1007\/s13187-017-1248-x","article-title":"Patients\u2019 perception of app-based educational and behavioural interventions for enhancing oral anticancer medication adherence","volume":"33","author":"Ali","journal-title":"J Cancer Educ"},{"issue":"19","key":"R21","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1200\/JCO.19.02699","article-title":"Randomized trial of text messaging to reduce early discontinuation of adjuvant aromatase inhibitor therapy in women with early-stage breast cancer: SWOG S1105","volume":"38","author":"Hershman","journal-title":"J Clin Oncol"},{"issue":"10","key":"R22","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.9559","article-title":"A mobile game for patients with breast cancer for chemotherapy self-management and quality-of-life improvement: randomized controlled trial","volume":"20","author":"Kim","journal-title":"J Med Internet Res"},{"issue":"6","key":"R23","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1089\/tmj.2018.0077","article-title":"The effect of telephone-based follow-up on adherence, efficacy, and toxicity of oral capecitabine-based chemotherapy","volume":"25","author":"Eldeib","journal-title":"Telemed J E Health"},{"issue":"6","key":"R24","doi-asserted-by":"publisher","first-page":"E874","DOI":"10.1097\/NCC.0000000000001030","article-title":"Effect of a smart pill bottle reminder intervention on medication adherence, self-efficacy, and depression in breast cancer survivors","volume":"45","author":"Park","journal-title":"Cancer Nurs"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2021.101969","article-title":"The effect of a mobile application on treatment adherence and symptom management in patients using oral anticancer agents: a randomized controlled trial","volume":"52","author":"Karaaslan-E\u015fer","journal-title":"Eur J Oncol Nurs"},{"issue":"83","key":"R26","first-page":"231","volume":"15","author":"Geynisman","journal-title":"Discov Med"},{"issue":"1","key":"R27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/CIN.0000000000000643","article-title":"Mobile health in adherence to oral anticancer drugs","volume":"39","author":"Gambalunga","journal-title":"Comput Inform Nurs"},{"issue":"6","key":"R28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/tmj.2015.0126","article-title":"Proof of concept of a mobile health short message service text message intervention that promotes adherence to oral anticancer agent medications: a randomized controlled trial","volume":"22","author":"Spoelstra","journal-title":"Telemed J E Health"},{"issue":"12","key":"R29","doi-asserted-by":"publisher","DOI":"10.2196\/mhealth.8349","article-title":"Mobile health intervention to increase oral cancer therapy adherence in patients with chronic myeloid leukemia (The REMIND System): clinical feasibility and acceptability assessment","volume":"5","author":"Pereira-Salgado","journal-title":"JMIR Mhealth Uhealth"},{"issue":"2","key":"R30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12553-018-0267-x","article-title":"Providers\u2019 perspectives on adherence to hormonal therapy in breast cancer survivors. Is there a role for the digital health feedback system?","volume":"9","author":"Hurtado-de-Mendoza","journal-title":"Health Technol"},{"issue":"2","key":"R31","doi-asserted-by":"publisher","DOI":"10.2196\/34833","article-title":"Investigation of intervention solutions to enhance adherence to oral anticancer medicines in adults: overview of reviews","volume":"8","author":"Dang","journal-title":"JMIR Cancer"},{"issue":"2","key":"R32","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.31838\/ijpr\/2021.13.02.185","article-title":"Digital intervention to improve oral chemotherapy adherence: systematic review","volume":"13","author":"Puspitasari","journal-title":"IJPR"},{"issue":"5","key":"R33","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jpainsymman.2018.07.021","article-title":"An automated intervention did not improve adherence to oral oncolytic agents while managing symptoms: results from a two-arm randomized controlled trial","volume":"56","author":"Sikorskii","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"R34","doi-asserted-by":"publisher","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"Liberati","journal-title":"Ann Intern Med"},{"key":"R35","unstructured":"EPOC taxonomy. Effective Practice and Organisation of Care (EPOC). 2015. URL: https:\/\/epoc.cochrane.org\/epoc-taxonomy [Accessed 09-05-2024]"},{"issue":"1","key":"R36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","article-title":"Concurrent and predictive validity of a self-reported measure of medication adherence","volume":"24","author":"Morisky","journal-title":"Med Care"},{"issue":"8","key":"R37","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/pds.1230","article-title":"Methods for evaluation of medication adherence and persistence using automated databases","volume":"15","author":"Andrade","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R38","unstructured":"Centre for Reviews and Dissemination. Systematic Reviews: CRD\u2019s Guidance for Undertaking Reviews in Health Care. CRD, University of York; 2009. URL: https:\/\/www.york.ac.uk\/media\/crd\/Systematic_Reviews [Accessed 30-05-2024]"},{"issue":"2","key":"R39","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","article-title":"A guideline of selecting and reporting intraclass correlation coefficients for reliability research","volume":"15","author":"Koo","journal-title":"J Chiropr Med"},{"key":"R40","unstructured":"Deeks JJ Higgins JPT Altman DG . Chapter 10: analyzing data and undertaking meta-analyses. In: Higgins JPT Thomas J Chandler J Cumpston M Li T Page MJ Welch VA , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 64. Cochrane; 2024. URL: https:\/\/training.cochrane.org\/handbook [Accessed 09-04-2025]"},{"key":"R41","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","journal-title":"BMJ"},{"issue":"3","key":"R42","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1177\/1536867X1001000307","article-title":"Metaan: random-effects meta-analysis","volume":"10","author":"Kontopantelis","journal-title":"The Stata Journal: Promoting communications on statistics and Stata"},{"issue":"2","key":"R43","doi-asserted-by":"publisher","first-page":"133","DOI":"10.6004\/jnccn.2019.7354","article-title":"Randomized trial of a smartphone mobile app to improve symptoms and adherence to oral therapy for cancer","volume":"18","author":"Greer","journal-title":"J Natl Compr Canc Netw"},{"issue":"8","key":"R44","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1007\/s00520-020-05955-3","article-title":"Effectiveness of a nurse-led telephone follow-up in the therapeutic management of patients receiving oral antineoplastic agents: a randomized, multicenter controlled trial (ETICCO study)","volume":"29","author":"Bouleftour","journal-title":"Support Care Cancer"},{"issue":"6","key":"R45","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/s41591-022-01788-1","article-title":"Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial","volume":"28","author":"Mir","journal-title":"Nat Med"},{"issue":"9","key":"R46","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1111\/jan.12978","article-title":"Impact of tailored patient education on adherence of patients with chronic myeloid leukaemia to tyrosine kinase inhibitors: a randomized multicentre intervention study","volume":"72","author":"Kek\u00e4le","journal-title":"J Adv Nurs"},{"issue":"6","key":"R47","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1007\/s11764-022-01209-9","article-title":"Supporting women\u2019s health outcomes after breast cancer treatment comparing a text message intervention to usual care: the EMPOWER-SMS randomised clinical trial","volume":"17","author":"Singleton","journal-title":"J Cancer Surviv"},{"key":"R48","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2020.06.012","article-title":"Improving medication adherence with adjuvant aromatase inhibitor in women with breast cancer: a randomised controlled trial to evaluate the effect of short message service (SMS) reminder","volume":"53","author":"Tan","journal-title":"Breast"},{"issue":"3","key":"R49","first-page":"189","volume":"1","author":"Martin","journal-title":"Ther Clin Risk Manag"},{"issue":"8","key":"R50","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1097\/MIB.0000000000001194","article-title":"Inflammatory bowel disease pharmacist adherence counseling improves medication adherence in Crohn\u2019s disease and ulcerative colitis","volume":"23","author":"Tiao","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"R51","doi-asserted-by":"publisher","DOI":"10.2196\/46979","article-title":"Co-design, development, and evaluation of a mobile solution to improve medication adherence in cancer: design science research approach","volume":"10","author":"Dang","journal-title":"JMIR Cancer"},{"issue":"9","key":"R52","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1007\/s11606-021-06648-1","article-title":"An adaptable framework for factors contributing to medication adherence: results from a systematic review of 102 conceptual frameworks","volume":"36","author":"Peh","journal-title":"J Gen Intern Med"},{"issue":"6","key":"R53","doi-asserted-by":"publisher","first-page":"151091","DOI":"10.1016\/j.soncn.2020.151091","article-title":"Digitally-enabled remote care for cancer patients: here to stay","volume":"36","author":"Kaye","journal-title":"Semin Oncol Nurs"},{"key":"R54","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2019.11.004","article-title":"Telemedicine interventions for medication adherence in mental illness: a systematic review","volume":"62","author":"Basit","journal-title":"Gen Hosp Psychiatry"},{"issue":"2","key":"R55","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/asi1020014","article-title":"A review of medication adherence monitoring technologies","volume":"1","author":"Aldeer","journal-title":"ASI"},{"issue":"6","key":"R56","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1188\/15.ONF.647-657","article-title":"Feasibility of a text messaging intervention to promote self-management for patients prescribed oral anticancer agents","volume":"42","author":"Spoelstra","journal-title":"Oncol Nurs Forum"},{"key":"R57","doi-asserted-by":"publisher","DOI":"10.1177\/20552076221129093","article-title":"The digital rainbow: digital determinants of health inequities","volume":"8","author":"Jahnel","journal-title":"Digit Health"},{"key":"R58","unstructured":"Exploring the UK\u2019s digital divide. Office for National Statistics. 2019. URL: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/householdcharacteristics\/homeinternetandsocialmediausage\/articles\/exploringtheuksdigitaldivide\/2019-03-04 [Accessed 09-05-2024]"},{"key":"R59","unstructured":"Mobile fact sheet. Center PR. 2021. URL: https:\/\/www.pewresearch.org\/internet\/fact-sheet\/mobile\/ [Accessed 09-04-2025]"},{"key":"R60","unstructured":"Measuring digital development. Facts and figures 2021. Union. IT. 2021. URL: https:\/\/www.itu.int\/en\/ITU-D\/Statistics\/Documents\/facts\/FactsFigures2021.pdf [Accessed 21-12-2024]"},{"issue":"1","key":"R61","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12939-023-02055-6","article-title":"Reducing intervention- and research-induced inequalities to tackle the digital divide in health promotion","volume":"22","author":"K\u00f6nig","journal-title":"Int J Equity Health"},{"issue":"13","key":"R62","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1111\/1471-0528.15199","article-title":"Randomised controlled trials\u2014the gold standard for effectiveness research","volume":"125","author":"Hariton","journal-title":"BJOG"},{"issue":"7658","key":"R63","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1136\/bmj.a117","article-title":"Reasons or excuses for avoiding meta-analysis in forest plots","volume":"336","author":"Ioannidis","journal-title":"BMJ"},{"issue":"4","key":"R64","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s13142-015-0315-2","article-title":"Self-report measures of medication adherence behavior: recommendations on optimal use","volume":"5","author":"Stirratt","journal-title":"Transl Behav Med"}],"container-title":["JMIR Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cancer.jmir.org\/2025\/1\/e64208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:30:35Z","timestamp":1785537035000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancer.jmir.org\/2025\/1\/e64208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":64,"URL":"https:\/\/doi.org\/10.2196\/64208","relation":{},"ISSN":["2369-1999"],"issn-type":[{"value":"2369-1999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,16]]},"article-number":"v11i3e64208"}}